PUBLICATIONS

    • Synaptic terminal density early in the course of schizophrenia: an in vivo UCB-J positron emission tomographic imaging study of synaptic vesicle glycoprotein 2A (SV2A). (2023 in preparation)
    • R Mehrotra and A Mukherjee (2013) The characteristics of law breaking behaviour in First Episode Psychosis Poster and Abstract at the European Congress of Psychiatry 2013
    • S Otero and Ravi Mehrotra (2009) Structural neuroimaging in first-episode psychosis, Technology Appraisal 136: Use of neuroimaging in early intervention service patients in Hounslow Abstract submission at European Congress of Psychiatry 2011
    • Anantha P. P. Anilkumar, Veena Kumari, Ravi Mehrotra, et al (2008) An fMRI study of face encoding and recognition in first-episode schizophrenia Acta Neuropsychiatrica June 2008 – Vol. 20 Issue 3, pages 129–138
    • Veena Kumari, Anantha PP Anilkumar, Dominic H ffytche, Ravi Mehrotra et al (2008) Neural Effects of Ziprasidone Monotherapy in First-Episode Schizophrenia: A Longitudinal Study using fMRI and a Procedural Learning Paradigm Journal Clinical Schizophrenia & Related Psychoses. Volume 1, Number 4 / 317-327
    • Postma P,Gray JA,Sharma T,Geyer M,Mehrotra R et al (2006). A behavioural and functional neuroimaging investigation into the effects of nicotine on sensorimotor gating in healthy subjects and persons with schizophrenia Psychopharmacology (Berl). Feb;184(3-4):589-599
    • Young AM, Kumari V, Mehrotra R et al (2005). Disruption of learned irrelevance in acute schizophrenia in a novel continuous within-subject paradigm suitable for fMRI Behav Brain Res. Jan 30;156(2):277-88.
    • Das M, Kumari V, Soni W, Ettinger U, Binneman B, Hughes C, Mehrotra R et al(2004). Neurological soft signs and their relationship to cognitive and clinical efficacy of atypical antipsychotics in schizophrenia. Schizophr Bull. 2004; 30(2): 241-53.
    • Kumari V, Zachariah E, Galea A, Jones HC, Das M, Mehrotra R et al (2003). Effects of acute procyclidine administration on prepulse inhibition of the startle response in schizophrenia: a double-blind, placebo-controlled study. J Psychopharmacol. Mar;17(1):89-95.
    • Zachariah E, Kumari V, Galea A, Das M, Mehrotra R, et al.(2002). Effects of oral procyclidine administration on cognitive functions in healthy subjects: implications for schizophrenia J Clin Psychopharmacol. Apr;22(2):224-6.
    • Kumari V, Zachariah E, Mehrotra R et al (2001). Effects of procyclidine on prepulse inhibition of the acoustic startle response in healthy human volunteers. Psychopharmacology Mar; 154 (3): 221-9.
    • Mehrotra R et al (2000). Neurological soft signs in schizophrenia: cognitive, clinical and structural correlates. Schizophrenia Research, 41 (1), 262 (abstract).
    • Soni W, Mehrotra R et al (2000). Change in negative symptoms with risperidone predicts improved quality of life in schizophrenia. Schizophrenia Research, 41 (1), 66 (abstract).